Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: GENEIMMUNE BIOTECHNOLOGY CORP
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-06-26 to 2019-07-10
Current total value of award: $98958.95
Description: DE-OBLIGATE EXCESS FUNDS FOR CLOSE OUT PER FAR PART 4.804.5 (15) AND FAR PART 13